Insulin resistance happens when your cells stop responding normally to insulin, the hormone that moves sugar from your blood into your cells for energy. Instead of unlocking the door to let glucose in, insulin essentially finds the locks have been changed. Your pancreas compensates by producing more insulin, but over time this system breaks down, leading to elevated blood sugar and, eventually, type 2 diabetes. The causes range from excess body fat and poor sleep to your genes and even chemicals in everyday products.
How Cells Become Resistant
Insulin works by binding to a receptor on the surface of your cells, which triggers a chain of internal signals that ultimately lets glucose enter. The first major link in that chain is a molecule called IRS-1, which activates a second molecule that opens the gates for glucose. In insulin resistance, this signaling chain gets disrupted at its earliest steps.
The primary disruption is a chemical modification to IRS-1 that weakens its ability to pass the insulin signal forward. Several stress signals inside the cell can trigger this modification, including problems with mitochondria, the tiny power plants inside each cell. When mitochondria aren’t functioning well, they activate enzymes that essentially put the brakes on insulin signaling before it can do its job. A second, independent defect involves the overproduction of a regulatory protein (p85α) that crowds out the normal signaling process. In most cases of clinically obvious insulin resistance, both defects are at work simultaneously.
Excess Body Fat and Inflammation
Carrying excess weight, particularly around the midsection, is the single most common driver of insulin resistance. But it’s not just the fat itself. It’s what the fat does. Visceral fat, the deep abdominal fat that surrounds your organs, behaves like an active organ, releasing inflammatory molecules into your bloodstream.
In people with obesity, immune cells called macrophages accumulate in fat tissue and shift into an aggressive, inflammatory state. These macrophages pump out inflammatory signals, most notably TNF-alpha, IL-1beta, and IL-6, that travel through the bloodstream and interfere with insulin signaling in fat cells, muscle cells, and liver cells. TNF-alpha, for example, activates internal pathways that directly block the insulin signal inside cells. IL-6 triggers a separate pathway that promotes the degradation of key insulin-signaling proteins, effectively dismantling the machinery your cells need to respond to insulin.
This creates a vicious cycle: more fat leads to more inflammation, which worsens insulin resistance, which promotes further fat storage.
How Fructose Affects Your Liver
Not all sugars behave the same way in your body. Fructose, found in table sugar, high-fructose corn syrup, and sweetened beverages, is processed almost exclusively by the liver and is far more likely to be converted into fat than glucose is. This process, called de novo lipogenesis, is at the heart of how excess fructose drives insulin resistance.
The key difference between fructose and glucose metabolism is that fructose bypasses the normal regulatory checkpoints. When your liver processes glucose, built-in feedback mechanisms slow things down when energy stores are full. Fructose metabolism has no such brakes. It flows through the pathway without restraint, flooding the liver with raw material for fat production. Fructose also activates genetic switches that ramp up fat-making machinery and, in a self-reinforcing loop, increase the liver’s capacity to absorb and process even more fructose.
The fat produced through this process doesn’t just accumulate in the liver (though it does cause fatty liver). It generates specific byproducts, particularly diacylglycerol and ceramides, that directly impair insulin signaling in liver cells. Diacylglycerol activates an enzyme that blocks the insulin receptor’s ability to function, while ceramides shut down a downstream step in the signaling chain. On top of this, fructose impairs mitochondrial function in the liver, reducing the organ’s ability to burn fat for energy and compounding the problem.
Gut Bacteria and “Metabolic Endotoxemia”
Your gut microbiome plays a surprisingly direct role in insulin sensitivity. In people who eat high-fat diets or carry excess weight, the intestinal lining becomes more permeable, allowing fragments of bacterial cell walls, specifically a molecule called lipopolysaccharide (LPS) from certain gut bacteria, to leak into the bloodstream. This condition is sometimes called metabolic endotoxemia.
Once in the blood, LPS activates immune receptors on cells throughout the body. These receptors trigger the same inflammatory pathways that visceral fat activates, including the production of TNF-alpha and IL-6. In muscle cells specifically, this immune activation leads to the breakdown of key insulin-signaling proteins, reducing glucose uptake. The composition of your gut bacteria matters too. Diets low in fiber and high in processed foods tend to favor bacterial species that produce more LPS, while fiber-rich diets promote species that strengthen the gut barrier and produce beneficial metabolites.
Sleep Deprivation and Stress
Even a single night of missed sleep measurably worsens insulin sensitivity. In a controlled study of healthy subjects, 24 hours of sleep deprivation significantly raised blood sugar levels during insulin testing compared to baseline, with no corresponding change in cortisol. This means the effect isn’t simply about stress hormones. Sleep loss appears to impair insulin signaling through other mechanisms, possibly involving increased inflammation and changes in how the nervous system regulates metabolism.
Chronic sleep restriction, the kind many people experience week after week, compounds these effects. Getting fewer than six hours per night on a regular basis is consistently associated with higher insulin resistance and greater risk of type 2 diabetes. Chronic psychological stress does raise cortisol, which independently promotes insulin resistance by stimulating the liver to release more glucose and encouraging fat storage in the abdominal area.
Genetic Predisposition
Some people are genetically wired for insulin resistance regardless of their lifestyle. Researchers have identified over a dozen gene variants that increase susceptibility. One of the most well-studied is a variant near the IRS1 gene, the same signaling molecule that gets disrupted in insulin resistance. People who carry the risk version of this variant have lower levels of the IRS-1 protein and reduced insulin signaling activity during insulin exposure.
Another striking example comes from a variant in TBC1D4, found at high frequency in the Greenlandic population. This variant disrupts a protein needed for insulin-stimulated glucose uptake in skeletal muscle, leading to higher fasting blood sugar and reduced insulin sensitivity. Other implicated genes affect fat metabolism, appetite regulation, and cholesterol processing. Researchers have combined multiple variants into genetic risk scores and found that people carrying 17 or more insulin resistance risk variants are at significantly higher risk of type 2 diabetes, coronary artery disease, and hypertension, even if they are relatively lean. This helps explain why some thin individuals still develop insulin resistance and metabolic disease.
Environmental Chemicals
A growing body of evidence points to everyday chemical exposures as an underappreciated contributor. Three classes of compounds stand out.
Phthalates, found in plastics, food packaging, and personal care products, disrupt receptors involved in fat metabolism and energy balance. In rodent studies, exposure to the common phthalate DEHP reduces pancreatic insulin production and alters the structure of insulin-producing cells. In human populations, higher levels of phthalate metabolites in urine have been linked to increased risk of type 2 diabetes across multiple studies, including large cohorts of Korean adults, men in Shanghai, and middle-aged women in the United States.
PFAS, the “forever chemicals” found in nonstick cookware, water-resistant clothing, and contaminated drinking water, have been linked to higher HOMA-IR scores (a standard measure of insulin resistance). One study found that doubling blood concentrations of two common PFAS compounds was associated with increased HOMA-IR, higher fasting proinsulin, and elevated HbA1c. Childhood exposure to PFOA has been linked to reduced function of insulin-producing beta cells later in life.
Bisphenol A (BPA), used in plastic bottles and can linings, has been associated with hyperinsulinemia and insulin resistance at higher urinary levels. Changes in insulin release have been observed in humans after consuming even a single dose of BPA.
How Much Weight Loss Helps
If excess weight is driving your insulin resistance, the good news is that you don’t need to reach an ideal body weight to see improvement. In a study tracking progressive weight loss, remission of hyperinsulinemia began at less than 10% weight loss. At that stage, about 21% of participants saw their insulin resistance resolve, and nearly half returned to normal insulin timing patterns. As weight loss increased, the improvement rates climbed steadily. By the time participants had lost 30% of their body weight, 100% had resolved their insulin resistance and abnormal insulin secretion patterns.
For someone weighing 200 pounds, 10% means losing 20 pounds, enough to start seeing real metabolic changes. The relationship is dose-dependent: more weight loss produces more improvement, but the first 5 to 10% delivers outsized benefits relative to the effort involved.
How Insulin Resistance Is Measured
Insulin resistance doesn’t show up on a standard blood sugar test until it’s fairly advanced. The most commonly used clinical tool is the HOMA-IR score, calculated from your fasting blood sugar and fasting insulin levels. A recent large biobank study identified a HOMA-IR cutoff of 1.88 or higher as indicating insulin resistance, based on the 75th percentile in insulin-sensitive individuals. Other useful markers include the triglyceride-to-HDL ratio (a value of 1.72 or higher suggests resistance) and the triglyceride-glucose index. These are particularly helpful because they rely on tests that are already part of routine bloodwork, making screening accessible even when fasting insulin levels aren’t ordered.